Group items tagged

Testosterone therapy in men with CHF found to increase exercise capacity, reduced the Q-T interval in men, improved muscle strength in men, and was found to be safe in meta-analysis.

Taurine an effective adjuvant in treatment of CHF.  Also shown to be safe.

Tynor Compression Stocking Below Knee Compression Stockings provide controlled compression to the legs to squeeze away abnormal back flow of blood into the superficial veins that lie just beneath the surface of the skin from the perforating veins. It is used in all forms of venous disease including blood pools or congests in legs. Severe varicose veins and discoloration to sores, ulcers and potentially life-threatening blood clots. Light weight. Four way stretch. Freely breathable. Soft and comfortable. Tynor Compression Stocking Below Knee Features Made from soft nylon yarn and spandex Strong and durable. Dermophillic. Optimal compression. Excellent aesthetics. Excellent Color fastness. Four-way stretchability Offers optimal compression. Snug fitting. Double layered Retains body heat effectively. Provides therapeutic warmth. Quicker healing. Strong and durable. Tapered shape and Controlled compression Uniform compression even on uneven limb surface. Offers graded compression high to low from toe upwards. Effective blood evacuation. Open toe design Reduces wear and tear. Easy to wear. Compatible to toe rings or other jewelry items. Tynor Compression Stocking Below Knee Measurements

Meta-analysis shows that coQ10 "may" improve heart function in those with CHF.

Taurine safe and effect in CHF.

free T3 is critical in the heart healing post MI.  Hypothyroidism and CHF share many hemodynamic and cardiovascular similarities.

IV T3 was given to patients with chronic heart failure.  What the study found may surprise you: improved heart function (ventricular), improved BNP, decrease heart rate, no side effects.  T3 has been shown to be more predictive of cardiac death in those with cardiac disease, than elevated lipids or decreased ejection fraction.

Patients with CHF often have low T3 levels.  In this study, IV T3 was shown to be safe and well tolerated

This early in the evaluation: but testosterone therapy in those men with CHF is of considerable benefit.  This would improve the catabolic:anabolic state, reduce inflammation, improve strength/endurance and reduce CVD risk

Good article.  Heart failure in men associated with lower Total Testosterone and estimated Free Testosterone. The severity of disease was associated with lower Testosterone levels.   I wish they would have measured free levels not estimated them.   Increased SHBG concentrations was associated increased CHF as well. This study found no association with mortality.

reverse T3 and the free T3:rT3 can be used to assess prognosis of those with CHF.

Great review by Morgentaler of Testosterone and CVD.  He highlights the significant flaws in the JAMA and the NEJM articles of Testosterone therapy risks.  Morgentaler highlights the significant evidence that points to low T and increased risk of CVD. On contention I have, is Morgantaler seems to flip aside the massive uptick of Testosterone use in the US as compared to other countries.  The evidence definitely points to Testosterone therapy as being safe in those with low T, but there is definitely a problem of significant Testosterone doping that is taking place as well.

Review of 4 studies found that Testosterone therapy improved exercise capacity in those patients with heart failure.

Low bioavailable Testosterone associated with increased IL-1beta and TNF-alpha in men with CHF.

Testosterone in men with CHF found to improve diastolic function and exercise distance versus placebo.  

dopamine has benefit in CHF.  Actually, use to be a therapy employed.

Dopamine improves chronic CHF via its interactions with the dopamine receptors.